2017
Contrast Agents for MR Imaging
Czeyda-Pommersheim F, Martin DR, Costello JR, Kalb B. Contrast Agents for MR Imaging. Magnetic Resonance Imaging Clinics Of North America 2017, 25: 705-711. PMID: 28964460, DOI: 10.1016/j.mric.2017.06.011.ChaptersConceptsAdverse eventsContrast mediumMR imagingCommon adverse eventsOral MR contrast agentGadolinium-based contrastContrast agentsOral contrast agentSpecific clinical questionsExcellent safety recordCT contrast mediaIron-based agentVariety of agentsLower incidenceClinical questionsSpecific contrast agentsClinical useMR contrast agentsSafety recordAgentsImagingIncidencePharmacology
2013
Free-Breathing, Motion-Corrected Late Gadolinium Enhancement Is Robust and Extends Risk Stratification to Vulnerable Patients
Piehler K, Wong T, Puntil K, Zareba K, Lin K, Harris D, Deible C, Lacomis J, Czeyda-Pommersheim F, Cook S, Kellman P, Schelbert E. Free-Breathing, Motion-Corrected Late Gadolinium Enhancement Is Robust and Extends Risk Stratification to Vulnerable Patients. Circulation Cardiovascular Imaging 2013, 6: 423-432. PMID: 23599309, PMCID: PMC4066466, DOI: 10.1161/circimaging.112.000022.Peer-Reviewed Original ResearchAdultAgedArtifactsBreath HoldingCardiac-Gated Imaging TechniquesChi-Square DistributionContrast MediaDisease ProgressionFemaleGadoliniumHeart FailureHeterocyclic CompoundsHospitalizationHumansImage Interpretation, Computer-AssistedLinear ModelsLogistic ModelsMagnetic Resonance Imaging, CineMaleMiddle AgedMyocardial InfarctionMyocardiumOdds RatioOrganometallic CompoundsPredictive Value of TestsPrognosisProportional Hazards ModelsProspective StudiesRespirationRisk FactorsTime Factors